NIC	Niclosamide
NEN	Niclosamide alcohol amine salt
NPP	Niclosamide pipera-zine
NASH	Nonalcoholic steatohepatitis
AR	Androgen receptor
ER	Endoplasmic reticulum
CRPC	Castration-resistant prostate cancer
NCSLC	Non-small-cell lung cancer
OHPP	Octenylsuccinate hydroxypropyl phytoglycogen
CPs	Chimeric polypeptides
NIC-NCT	Co-crystals of niclosamide-nicotinamide
NSPT	Niclosamide stearate prodrug therapeutic
Nano-NIC	Nanosuspension of niclosamide
NLM-NCs	Niclosamide nanocrystals
SARS	Severe acute respiratory syndrome coronavirus
MERS-CoV	Middle East respiratory syndrome coronavirus
ZIKV	Zika virus
JEV	Japanese encephalitis virus
HCV	Hepatitis C V
EBOV	Ebola virus
HRV	Human rhinovirus
CHIKV	Chikungunya virus
HADV	Human adenovirus
EBV	Epstein–Barr virus
CPE	Cytopathic effect
FDA	Food and Drug Administration
WHO	The World Health Organization
ROS	Reactive oxygen species
T2D	Type 2 diabetes
CRC	Colorectal cancer
NPC	Nasopharyngeal cancer
AML	Acute myeloid leukemia
CML	Chronic myeloid leukemia
HCC	Hepatocellular carcinoma
EMT	Epithelial–mesenchymal transition
CSCs	Cancer stem cells
d-TPP	Dodecyl-TPP
TOS	Tumorospheres
CTC	Circulating tumor cell
MCTS	Multicellular tumor spheroid
SPS	Side population spheres
CDKs	Cyclin-dependant kinase
TID	Ter in die
GVHD	Graft versus host disease